A. Hamann

A. Hamann, P. Kann, G. Tamagno, 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Genetics of obesity and obesity-related hypertension.

Arya M. Sharma, A. Hamann, 2002, Seminars in nephrology.

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.

H. Brenner, D. Rothenbacher, D. Twardella, 2007, European heart journal.

SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.

R. Neuwirth, A. Hamann, P. Nawroth, 2005, Diabetes care.

Survey to estimate the prevalence of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c measurement upon admission

A. Hamann, D. Müller-Wieland, M. Merkel, 2018, International journal of clinical practice.

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].

F. Thaiss, G. Wolf, D. C. Han, 1999, Kidney international.

High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men.

P. Lepper, B. Allolio, A. Hamann, 2008, Atherosclerosis.

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

T. Schöndorf, A. Hamann, S. Matthaei, 2006, Metabolism: clinical and experimental.

No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications

A. Hamann, A. Bierhaus, P. Nawroth, 2005, Diabetes, obesity & metabolism.

New treatments for diabetic neuropathy: Pathogenetically oriented treatment

A. Hamann, P. Nawroth, A. Bierhaus, 2003, Current diabetes reports.

Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients

A. Hamann, A. Bierhaus, P. Nawroth, 2007, Diabetologia.

A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes.

J. Schneider, M. Andrassy, E. Schleicher, 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia.

B. Lowell, J. Flier, A. Hamann, 1996, Endocrinology.

Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects.

H. Münzberg, J. Hebebrand, A. Hinney, 1999, European journal of endocrinology.

Development of morbid obesity in transgenic mice following the genetic ablation of brown adipose tissue

B. Lowell, J. Flier, A. Hamann, 1993 .

Chronic leptin treatment does not prevent the development of obesity in transgenic mice with brown fat deficiency

A. Hamann, C. Kausch, S. Matthaei, 1997, Diabetologia.

Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Hep G2 cells.

Li Yuan, R. Ziegler, A. Hamann, 2003, Acta pharmacologica Sinica.

Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts.

A. Hamann, C. Kausch, S. Matthaei, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM).

C. Mantzoros, J. Flier, A. Vidal-Puig, 1995, Biochemical and biophysical research communications.

Development of obesity in transgenic mice after genetic ablation of brown adipose tissue

B. Lowell, J. Flier, A. Hamann, 1993, Nature.

Analysis of the uncoupling protein-1 (UCP1) gene in obese and lean subjects: Identification of four amino acid variants

H. Münzberg, J. Hebebrand, A. Hinney, 1998, International Journal of Obesity.

Regulation of energy balance by leptin.

A. Hamann, S. Matthaei, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[Progress in obesity research].

A. Hamann, S. Matthaei, 1997, Medizinische Monatsschrift fur Pharmazeuten.

Elevated plasma endothelin-1 levels in diabetes mellitus.

J. Schneider, U. Sommer, A. Hamann, 2002, American journal of hypertension.

Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma.

B. Markus, R. Blaheta, A. Hamann, 1992, Human immunology.

Identification of a deletion variant in the gene encoding the human alpha(2A)-adrenergic receptor.

H. Münzberg, J. Hebebrand, A. Hinney, 2001, European journal of endocrinology.

Comparison of Fixed-dose Rosiglitazone/Metformin Combination Therapy with Sulphonylurea Plus Metformin in Overweight Individuals with Type 2 Diabetes Inadequately Controlled on Metformin Alone

J. García-Puig, A. Hamann, M. Stewart, 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Reduction of Postprandial Hyperglycemia in Patients with Type 2 Diabetes Reduces NF-κB Activation in PBMCs

B. Isermann, S. Schiekofer, A. Hamann, 2004 .

The −174G>C IL-6 Gene Promoter Polymorphism and Diabetic Microvascular Complications

A. Hamann, A. Bierhaus, P. Nawroth, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction

H. Hutter, Paul J Thornalley, M. Zeier, 2009, Diabetes.

Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.

J. Schneider, M. Zeier, A. Hamann, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Activation of tubular epithelial cells in diabetic nephropathy.

M. Andrassy, E. Schleicher, B. Yard, 2002, Diabetes.

Neural driven angiogenesis by overexpression of nerve growth factor

S. Ergün, N. Kilic, A. Hamann, 2006, Histochemistry and Cell Biology.

Tissue factor as a link between wounding and tissue repair.

M. Andrassy, Bao-sheng Chen, T. Luther, 2005, Diabetes.

Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

B. Lowell, J. Flier, A. Hamann, 1995, Nature Medicine.

No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region

F. Poustka, B. Herpertz-Dahlmann, J. Hebebrand, 1998, Molecular Psychiatry.

Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to body weight and in anorexia nervosa.

F. Poustka, K. Lesch, K. Grzeschik, 1997, Life sciences.

Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity.

B. Lowell, J. Flier, B. Kahn, 1995, The Journal of clinical investigation.

Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis1

F. Thaiss, G. Wolf, R. Stahl, 1999 .

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

B. Spiegelman, M. Jimenez-Linan, B. Lowell, 1996, The Journal of clinical investigation.

Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study

M. Górska, A. Hamann, H. Toplak, 2007, International Journal of Obesity.

Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

H. Hutter, H. Hammes, M. Zeier, 2008, Aging cell.

Effect of thiol antioxidant on body fat and insulin reactivity

W. Dröge, R. Kinscherf, W. Hildebrandt, 2004, Journal of Molecular Medicine.

Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.

J. Schneider, A. Hamann, P. Nawroth, 2005, Diabetes care.

Microvascular alterations in diabetic mice correlate with level of hyperglycemia.

A. Hamann, P. Algenstaedt, W. Rüther, 2003, Diabetes.

Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes.

B. Isermann, V. Nosikov, A. Hamann, 2004, Diabetes care.

Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes.

H. Klein, H. Benecke, A. Hamann, 1995, The Journal of endocrinology.

Variants in the human β1‐,β2‐ and β3‐adrenergic receptor genes are not associated with morbid obesity in children and adolescents

J. Hebebrand, A. Hinney, A. Hamann, 2004 .

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

H. Klein, J. Flier, H. Benecke, 1991, Diabetes.

Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.

J. Schneider, S. Schiekofer, A. Hamann, 2004, Atherosclerosis.

Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia

W. Hacke, C. Dörfer, A. Grau, 2004, Journal of Neurology.

Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.

J. Schneider, A. Hamann, P. Nawroth, 2004, Diabetes care.

Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans

H. Hutter, M. Brownlee, A. Hamann, 2010, Aging cell.

Activation of Tubular Epithelial Cells in Diabetic

M. Andrassy, E. Schleicher, B. Yard, 2002 .

Long-Term Treatment of Central Cushing's Syndrome with Rosiglitazone

H. Hammes, T. Schilling, M. Zeier, 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Raymond L. Forbes, A. Astrup, F. Greenway, 2017, The Lancet.

In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.

H. Klein, H. Benecke, H. Häring, 1993, Endocrinology.

Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes.

Li Yuan, R. Ziegler, A. Hamann, 2002, Chinese medical journal.

X‐PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced‐energy diet. Early response to treatment predicts weight maintenance

L. V. Van Gaal, G. Wittert, A. Hamann, 2005, Diabetes, obesity & metabolism.

Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.

J. Tuomilehto, A. Hamann, P. Durrington, 2004, Diabetes research and clinical practice.

Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes.

B. Isermann, A. Hamann, P. Nawroth, 2006, Diabetes care.

Moderate Weight Reduction in an Outpatient Obesity Intervention Program Significantly Reduces Insulin Resistance and Risk Factors for Cardiovascular Disease in Severely Obese Adolescents

A. Hamann, P. Nawroth, S. Lichtenstein, 2011, International journal of endocrinology.

Functional Polymorphisms of UCP 2 and UCP 3 Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 1 Diabetes

Per, Humpert, Peter, 2005 .

External electric muscle stimulation improves burning sensations and sleeping disturbances in patients with type 2 diabetes and symptomatic neuropathy.

T. Schilling, A. Hamann, P. Nawroth, 2009, Pain medicine.

Efficiacy and Safety of Partial Use of a Formula Diet in Extreme Obese Adolescents

A. Hamann, P. Nawroth, S. Lichtenstein, 2011 .

[AGE-RAGE: a hypothesis or a mechanism?].

B. Isermann, A. Hamann, P. Nawroth, 2004, Herz.

Screening for variability in the ciliary neurotrophic factor (CNTF) gene: No evidence for association with human obesity

H. Münzberg, J. Hebebrand, A. Hinney, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Improved Vascular Function upon Pioglitazone Treatment in Type 2 Diabetes is not Associated with Changes in Mononuclear NF-κB Binding Activity

S. Buchbinder, A. Hamann, A. Bierhaus, 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

C. elegans as model for the study of high glucose mediated lifespan reduction Running title: Glucose regulates lifespan in C. elegans

H. Hutter, M. Zeier, M. Brownlee, 2009 .

C332C genotype of glyoxalase 1 and its association with late diabetic complications.

A. Hamann, A. Bierhaus, P. Nawroth, 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Promoter Polymorphisms of UCP1, UCP2, and UCP3 are not Associated with Diabetic Microvascular Complications in Type 2 Diabetes

A. Hamann, A. Bierhaus, P. Nawroth, 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Metformin increases glucose transporter protein and gene expression in human fibroblasts.

H. Benecke, A. Hamann, S. Matthaei, 1993, Biochemical and biophysical research communications.

Evidence that metformin increases insulin-stimulated glucose transport by potentiating insulin-induced translocation of glucose transporters from an intracellular pool to the cell surface in rat adipocytes.

H. Klein, J. Flier, H. Benecke, 1992, Hormone and metabolic research. Supplement series.

Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes

J. Rosenstock, A. Hamann, S. Matthaei, 2008, Diabetes, obesity & metabolism.

O-50: A novel mechanism of cellular insulin resistance: Defective insulin-stimulated glucose transport due to malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with an insulin resistance syndrome

A. Niendorf, H. Joost, A. Hamann, 2009 .

A M55V Polymorphism in the SUMO4 Gene is Associated with a Reduced Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetes

A. Hamann, A. Bierhaus, P. Nawroth, 2007, Experimental and clinical endocrinology & diabetes.

[Differentiated treatment of diabetics with an acute coronary syndrome].

A. Hamann, C. Hamm, 2006, Deutsche medizinische Wochenschrift.